Article Details

Study establishes proof of concept for TLX592 in prostate cancer - Urology Times

Retrieved on: 2024-05-21 20:34:18

Tags for this article:

Click the tags to see associated articles and topics

Study establishes proof of concept for TLX592 in prostate cancer - Urology Times. View article details on hiswai:

Excerpt

... monoclonal antibodies (mAbs), while retaining target selectivity, internalization, and retention,” according to the company. 1. Read more. Prostate ...

Article found on: www.urologytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo